)
Catheter Precision (VTAK) investor relations material
Catheter Precision Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved significant clinical, commercial, and regulatory milestones in 2025, including CE Mark for LockeT and first commercial sales in Europe.
Expanded customer base by 32 across VIVO and LockeT platforms and had four abstracts accepted at a major industry meeting.
Acquired Flyte, entering the regional air mobility market and diversifying into two growth platforms: medical devices and aviation.
Financial highlights
2025 revenue reached $819 thousand, up 95% year-over-year from $420 thousand in 2024.
Gross margin improved to 92.3% in 2025 from 90.0% in 2024.
Net loss for 2025 was $17.2 million, with $7.8 million non-cash, compared to $16.6 million net loss and $7.5 million non-cash in 2024.
Q4 2025 revenue increased 60% to $238 thousand versus Q4 2024; gross margin was 91.6%.
Q4 2025 net loss was $5.3 million ($3.5 million non-cash) compared to $5.6 million ($3.1 million non-cash) in Q4 2024.
Outlook and guidance
Entering 2026 with two differentiated growth platforms in large addressable markets and strengthened capital resources.
Plans to scale Flyte aviation platform and continue commercialization of VIVO and LockeT.
Evaluating strategic alternatives to enhance valuation and investor visibility.
- Six proposals seek approval for new share issuances, a reverse split, and governance changes.VTAK
Proxy filing23 Mar 2026 - Shareholders will vote on major stock issuances and a reverse split at a virtual meeting in April 2026.VTAK
Proxy filing23 Mar 2026 - Six proposals seek approval for share issuances, a reverse split, and governance flexibility.VTAK
Proxy Filing13 Mar 2026 - Registering up to $20M in securities, with proceeds for operations and growth in cardiac EP tech.VTAK
Registration Filing16 Dec 2025 - Registering 12.86M shares for resale by PIPE investors; proceeds only from warrant exercises.VTAK
Registration Filing16 Dec 2025 - Annual meeting to vote on director, share issuances, reverse split, and auditor ratification.VTAK
Proxy Filing1 Dec 2025 - Annual meeting seeks approval for director, share issuances, reverse split, and auditor ratification.VTAK
Proxy Filing1 Dec 2025 - Special Meeting seeks approval for key capital, equity, and governance proposals.VTAK
Proxy Filing1 Dec 2025 - Special Meeting to vote on warrant exercises, share increase, equity plan, and auditor ratification.VTAK
Proxy Filing1 Dec 2025
Next Catheter Precision earnings date
Next Catheter Precision earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)